Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Burundi
Burundi: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 80.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Burundi, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Burundi is 80.0%, measured in 2025.
Compared with earlier readings it is up 23.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Burundi peaked at 85.0% in 2021 and was at its lowest, 0.0%, in 2000.
Burundi ranks 108th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Burundi, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 51.0% | — |
| 2014 | 60.0% | +17.6% |
| 2015 | 65.0% | +8.3% |
| 2016 | 72.0% | +10.8% |
| 2017 | 75.0% | +4.2% |
| 2018 | 77.0% | +2.7% |
| 2019 | 80.0% | +3.9% |
| 2020 | 83.0% | +3.8% |
| 2021 | 85.0% | +2.4% |
| 2022 | 85.0% | +0.0% |
| 2023 | 80.0% | -5.9% |
| 2024 | 80.0% | +0.0% |
| 2025 | 80.0% | +0.0% |
Burundi compared with similar countries
- Burundi's 80.0% is above the median for low income countries, which is 60.0%, 1.3× the median. (25 countries reporting)
- Burundi's 80.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 48.0% | 0.0% | 80.0% | 10 |
| 2020s | 82.2% | 80.0% | 85.0% | 6 |
Countries ranked near Burundi
More health data for Burundi
- Un projection of annual infant deaths, annual growth rate -1.03 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 929.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,143 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 26 (2025)
- Population ages 00-04, female, annual growth rate 0.736 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0003 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0759 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.7548 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0003 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Burundi?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Burundi was 80.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Burundi?
- The highest recorded value was 85.0% in 2021.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Burundi?
- The lowest recorded value was 0.0% in 2000.
- How does Burundi rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Burundi ranks 108th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Burundi?
- Over the last ten years it is up 23.1%. The long-run trend across the full record is volatile.
- Where does this Burundi data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).